The Bianchi Lab
The research interest of the Bianchi Lab is to discover the mechanisms regulating protein homeostasis in physiologic and pathologic states of plasma cell differentiation and the role that proteostasis plays in determining plasma cell fate. Our overall vision is to build a strong mechanistic foundation for the development of innovative treatments targeting plasma cell disorders such as AL amyloidosis and multiple myeloma, as well as the progression of precursor diseases monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
Welcome to the Bianchi Lab
Clinical Information
Amyloidosis Program
Learn about the Amyloidosis Program at Dana-Farber Cancer Institute.
Clinical Trials
Explore Dr. Bianchi's amyloidosis clinical trials at Dana-Farber.
